Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Sensient Technologies Corporation (NYSE: SXT) reported diluted earnings per share of 65 cents in the second quarter which includes restructuring costs of 9 cents per share. As adjusted, to remove the impact of the restructuring costs, diluted earnings per share were 74 cents, an all-time quarterly record and an increase of 5.7% over the 70 cents reported in the second quarter of 2012. Consolidated revenue reached a new quarterly record of $378.8 million compared to $367.8 million in the second quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.